• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管存在持续的淀粉样蛋白沉积,但托珠单抗治疗后淀粉样蛋白A淀粉样变性的临床快速改善:一例报告

Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.

作者信息

Yamagata Akira, Uchida Takahiro, Yamada Yuji, Nakanishi Takashi, Nagai Kazue, Imakiire Toshihiko, Oshima Naoki, Kumagai Hiroo

机构信息

Department of Nephrology and Endocrinology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Department of Rheumatology, National Defense Medical College, Tokorozawa, Saitama, Japan.

出版信息

BMC Nephrol. 2017 Dec 29;18(1):377. doi: 10.1186/s12882-017-0799-8.

DOI:10.1186/s12882-017-0799-8
PMID:29287589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5747944/
Abstract

BACKGROUND

Amyloid A amyloidosis is one of the most common forms of amyloidosis. It is secondary to rheumatoid arthritis, which is difficult to manage and has a poor prognosis. We present a patient with rheumatoid arthritis and amyloid A amyloidosis who was treated with tocilizumab, a humanized monoclonal antibody against interleukin 6 receptor, resulting in improvement in both proteinuria and gastrointestinal symptoms; however, amyloid deposition remained.

CASE PRESENTATION

A 67-year-old woman who had previously been treated for rheumatoid arthritis presented with abdominal pain and diarrhea. Right renal cell carcinoma was found, and amyloid A amyloidosis was diagnosed concomitantly based on colon biopsy. The renal cell carcinoma was resected, and the non-cancerous part of the renal tissue also showed amyloid A deposition. Following surgery, protein levels in the urine increased to the nephrotic range, and administration of tocilizumab was initiated, which resulted in resolution of the proteinuria. The patient's gastrointestinal symptoms were also alleviated. However, repeat colon biopsy showed amyloid deposition.

CONCLUSIONS

This case of amyloid A amyloidosis suggests that amyloid deposition indicates only structural change of the affected tissue, and that it is not amyloid deposition per se that causes the clinical symptoms of amyloidosis.

摘要

背景

淀粉样蛋白A淀粉样变性是淀粉样变性最常见的形式之一。它继发于类风湿关节炎,后者难以治疗且预后较差。我们报告一例类风湿关节炎合并淀粉样蛋白A淀粉样变性的患者,该患者接受了托珠单抗治疗,托珠单抗是一种抗白细胞介素6受体的人源化单克隆抗体,治疗后蛋白尿和胃肠道症状均有所改善;然而,淀粉样蛋白沉积仍然存在。

病例报告

一名67岁女性,既往曾接受类风湿关节炎治疗,现出现腹痛和腹泻。发现右肾细胞癌,同时根据结肠活检诊断为淀粉样蛋白A淀粉样变性。切除肾细胞癌,肾组织的非癌部分也显示有淀粉样蛋白A沉积。手术后,尿蛋白水平升至肾病范围,遂开始使用托珠单抗治疗,蛋白尿得以缓解。患者的胃肠道症状也得到缓解。然而,再次结肠活检显示有淀粉样蛋白沉积。

结论

该例淀粉样蛋白A淀粉样变性提示,淀粉样蛋白沉积仅表明受累组织的结构改变,并非淀粉样蛋白沉积本身导致淀粉样变性的临床症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be60/5747944/68500cc82527/12882_2017_799_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be60/5747944/674196ae90a9/12882_2017_799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be60/5747944/68500cc82527/12882_2017_799_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be60/5747944/674196ae90a9/12882_2017_799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be60/5747944/68500cc82527/12882_2017_799_Fig2_HTML.jpg

相似文献

1
Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.尽管存在持续的淀粉样蛋白沉积,但托珠单抗治疗后淀粉样蛋白A淀粉样变性的临床快速改善:一例报告
BMC Nephrol. 2017 Dec 29;18(1):377. doi: 10.1186/s12882-017-0799-8.
2
Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report.托珠单抗(抗白细胞介素-6)治疗晚期慢性肾脏病患者的AA型肾淀粉样变性:一例报告
J Nephrol. 2024 May;37(4):1147-1152. doi: 10.1007/s40620-023-01845-z. Epub 2024 Jan 11.
3
Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.托珠单抗在 Sweet 综合征相关淀粉样变性肾病中的应用:一例病例报告及文献复习。
CEN Case Rep. 2021 Feb;10(1):23-29. doi: 10.1007/s13730-020-00507-4. Epub 2020 Jul 17.
4
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.托珠单抗在组织学上改善了一名多中心Castleman病患者的AA型肾淀粉样变性:病例报告
Clin Nephrol. 2018 Sep;90(3):232-236. doi: 10.5414/CN109273.
5
Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.托珠单抗可维持合并 AA 淀粉样变性和终末期肾病的类风湿关节炎患者的肾功能:两例报告。
Clin Nephrol. 2021 Jan;95(1):54-61. doi: 10.5414/CN109971.
6
Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.成功使用托珠单抗治疗继发于潜伏性结核的快速进展性 AA 淀粉样变性肾病综合征患者。
Amyloid. 2011 Dec;18(4):235-9. doi: 10.3109/13506129.2011.613962. Epub 2011 Oct 12.
7
Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.托珠单抗改善了类风湿关节炎继发的 AA 淀粉样变性透析患者的心脏疾病。
Amyloid. 2012 Mar;19(1):37-40. doi: 10.3109/13506129.2011.636460. Epub 2012 Jan 20.
8
Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.成功使用人源化抗白细胞介素-6受体抗体托珠单抗治疗并发幼年特发性关节炎的淀粉样蛋白A淀粉样变性。
Arthritis Rheum. 2006 Sep;54(9):2997-3000. doi: 10.1002/art.22118.
9
Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.生物制剂治疗白细胞介素 6 治疗的类风湿关节炎相关淀粉样变性 A 淀粉样变:病例报告及文献复习。
Medicine (Baltimore). 2021 Aug 13;100(32):e26843. doi: 10.1097/MD.0000000000026843.
10
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.托珠单抗治疗活动性类风湿关节炎继发肠道淀粉样变性 A 沉积的疗效良好。
Clin Rheumatol. 2010 Oct;29(10):1195-7. doi: 10.1007/s10067-010-1422-6. Epub 2010 Mar 15.

引用本文的文献

1
Idiopathic AA amyloidosis presenting with initial abdominal pain: a case report and literature review.以腹痛为首发表现的特发性AA型淀粉样变性:一例病例报告及文献复习
Front Med (Lausanne). 2025 Aug 18;12:1640436. doi: 10.3389/fmed.2025.1640436. eCollection 2025.
2
Serum Amyloid A Protein-Associated Kidney Disease: Presentation, Diagnosis, and Management.血清淀粉样蛋白A蛋白相关性肾病:临床表现、诊断与管理
Kidney Med. 2022 Jun 26;4(8):100504. doi: 10.1016/j.xkme.2022.100504. eCollection 2022 Aug.
3
Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis.

本文引用的文献

1
Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature.以AA型淀粉样变性为表现的肾细胞癌:一例病例报告及文献复习
CEN Case Rep. 2014 May;3(1):68-74. doi: 10.1007/s13730-013-0088-8. Epub 2013 Aug 9.
2
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.抗白细胞介素1治疗与自身炎症性疾病相关的继发性淀粉样变性
Pediatr Nephrol. 2016 Apr;31(4):633-40. doi: 10.1007/s00467-015-3249-5. Epub 2015 Nov 12.
3
Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
白细胞介素-6水平升高与心脏转甲状腺素蛋白淀粉样变的不良预后相关。
World J Cardiol. 2021 Mar 26;13(3):55-67. doi: 10.4330/wjc.v13.i3.55.
4
Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.血清淀粉样蛋白 A 的重要生理功能和病理性失能的结构基础:穿了件疏水外衣的急性期蛋白
Curr Atheroscler Rep. 2020 Sep 24;22(11):69. doi: 10.1007/s11883-020-00888-y.
5
Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.托珠单抗在 Sweet 综合征相关淀粉样变性肾病中的应用:一例病例报告及文献复习。
CEN Case Rep. 2021 Feb;10(1):23-29. doi: 10.1007/s13730-020-00507-4. Epub 2020 Jul 17.
托珠单抗对白介素-6的治疗性阻断在AA型淀粉样变性和慢性炎症性疾病管理中的应用:病例系列及文献综述
Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S46-53. Epub 2015 Jun 29.
4
Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.托珠单抗对AA型淀粉样变性患者不同器官的治疗益处各异。
Case Rep Nephrol. 2014;2014:823093. doi: 10.1155/2014/823093. Epub 2014 Aug 12.
5
Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases.比较托珠单抗和抗 TNF 治疗在风湿性疾病相关淀粉样变性中的临床应用。
Mod Rheumatol. 2014 Jan;24(1):137-43. doi: 10.3109/14397595.2013.854048.
6
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.抗IL-6受体抗体托珠单抗治疗类风湿关节炎合并AA淀粉样变性患者的安全性和有效性研究。
Mod Rheumatol. 2014 May;24(3):405-9. doi: 10.3109/14397595.2013.844294. Epub 2013 Oct 21.
7
A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.一种新型核因子 κB 抑制剂,去羟甲基环氧奎宁,可改善嘌呤霉素氨基核苷诱导的小鼠肾病。
Am J Nephrol. 2013;37(4):302-9. doi: 10.1159/000348803. Epub 2013 Mar 19.
8
Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments.类风湿关节炎相关性淀粉样变性 A 病:发病机制与治疗。
Clin Exp Rheumatol. 2011 Sep-Oct;29(5):850-7. Epub 2011 Oct 31.
9
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.托珠单抗治疗活动性类风湿关节炎继发肠道淀粉样变性 A 沉积的疗效良好。
Clin Rheumatol. 2010 Oct;29(10):1195-7. doi: 10.1007/s10067-010-1422-6. Epub 2010 Mar 15.
10
Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.风湿性疾病中AA淀粉样变性的易感性:批判性综述。
Arthritis Rheum. 2009 Oct 15;61(10):1435-40. doi: 10.1002/art.24735.